53.00

0.73% -0.39

After Hours: 52.50 -0.50 -0.94%

Doximity Inc (DOCS)

Overview News Price History Option Chain Financials Why DOCS Down? Discussions Forecast

Doximity Inc stock is traded at $53.00, with a volume of 842.58K. It is down -0.73% in the last 24 hours and up +26.55% over the past month. Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Previous Close:

$53.39

Open:

$53.66

24h Volume:

842.58K

Relative Volume:

0.48

Market Cap:

$9.89B

Revenue:

$493.63M

Net Income/Loss:

$160.55M

P/E Ratio:

96.36

EPS:

0.55

Net Cash Flow:

$162.20M

1W Performance:

+9.96%

1M Performance:

+26.55%

6M Performance:

+85.83%

1Y Performance:

+121.57%

1-Day Range:

$52.90

$54.28

1-Week Range:

$48.21

$54.39

52-Week Range:

$22.96

$61.75

Doximity Inc Stock (DOCS) Company Profile

Name

Doximity Inc

Sector

Healthcare (1180)

Industry

Health Information Services (60)

Phone

(650) 549-4330

Address

500 THIRD STREET, SAN FRANCISCO

Employee

827

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

DOCS's Discussions on Twitter

Compare DOCS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DOCS Doximity Inc	53.00	9.89B	493.63M	160.55M	162.20M	0.80
VEEV Veeva Systems Inc	227.85	36.90B	2.57B	615.26M	996.76M	3.75
SOLV Solventum Corp	71.51	12.35B	8.26B	66.00M	1.17B	0.3682
TEM Tempus Ai Inc	62.59	9.85B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	101.54	8.75B	1.10B	105.67M	-197.98M	1.20

Doximity Inc Stock (DOCS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Initiated	Goldman	Neutral
Nov-14-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-13-24	Downgrade	Canaccord Genuity	Buy → Hold
Nov-08-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Nov-08-24	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-15-24	Upgrade	Barclays	Equal Weight → Overweight
Aug-09-24	Upgrade	Needham	Hold → Buy
Jul-18-24	Downgrade	Wells Fargo	Equal Weight → Underweight
Apr-25-24	Upgrade	JP Morgan	Underweight → Neutral
Feb-26-24	Initiated	Leerink Partners	Market Perform
Jan-03-24	Initiated	Barclays	Equal Weight
Jan-02-24	Upgrade	BofA Securities	Underperform → Neutral
Aug-09-23	Downgrade	Guggenheim	Buy → Neutral
Aug-09-23	Downgrade	Needham	Buy → Hold
Aug-03-23	Downgrade	Piper Sandler	Overweight → Neutral
May-01-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Oct-31-22	Initiated	Wells Fargo	Overweight
Oct-24-22	Initiated	Evercore ISI	In-line
Oct-13-22	Initiated	BTIG Research	Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold
Aug-05-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-28-22	Initiated	Berenberg	Buy
May-18-22	Reiterated	BofA Securities	Neutral
May-18-22	Reiterated	Goldman	Buy
May-18-22	Reiterated	Guggenheim	Buy
May-18-22	Reiterated	Jefferies	Buy
May-18-22	Reiterated	Morgan Stanley	Equal-Weight
May-18-22	Reiterated	Needham	Buy
Apr-07-22	Initiated	Guggenheim	Buy
Apr-04-22	Initiated	BofA Securities	Neutral
Feb-11-22	Initiated	Goldman	Buy
Dec-14-21	Downgrade	JP Morgan	Neutral → Underweight
Dec-02-21	Initiated	Jefferies	Buy
Nov-17-21	Initiated	Robert W. Baird	Outperform
Nov-10-21	Reiterated	Canaccord Genuity	Buy
Nov-10-21	Reiterated	Goldman	Neutral
Nov-10-21	Reiterated	Morgan Stanley	Equal-Weight
Nov-10-21	Reiterated	Needham	Buy
Nov-10-21	Reiterated	Piper Sandler	Overweight
Aug-26-21	Downgrade	JP Morgan	Overweight → Neutral
Jul-19-21	Initiated	Canaccord Genuity	Buy
Jul-19-21	Initiated	Goldman	Neutral
Jul-19-21	Initiated	JP Morgan	Overweight
Jul-19-21	Initiated	Morgan Stanley	Equal-Weight
Jul-19-21	Initiated	Piper Sandler	Overweight
Jul-19-21	Initiated	Raymond James	Outperform
Jul-19-21	Initiated	SVB Leerink	Outperform
Jul-19-21	Initiated	William Blair	Outperform

View All

Doximity Inc Stock (DOCS) Latest News

Nov 28, 2024

Doximity, Inc. (NYSE:DOCS) Q2 2025 Earnings Call Transcript - MSN

Nov 28, 2024

Robust Revenue Growth and Margin Expansion Lifted Doximity (DOCS) in Q3 - Insider Monkey

Nov 28, 2024

Nov 27, 2024

Doximity could benefit from RFK Jr. leading HHS: Jefferies - MSN

Nov 27, 2024

Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Swedbank AB - MarketBeat

Nov 27, 2024

Natixis Advisors LLC Has $1.39 Million Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat

Nov 27, 2024

Two Reasons to Like DOCS and One to Stay Skeptical - Yahoo Finance

Nov 27, 2024

Nov 26, 2024

Penserra Capital Management LLC Buys New Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat

Nov 26, 2024

Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Algert Global LLC - MarketBeat

Nov 26, 2024

Nov 25, 2024

Doximity's SWOT analysis: healthcare tech stock shows resilience amid challenges - Investing.com

Nov 25, 2024

Loomis Sayles & Co. L P Decreases Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat

Nov 25, 2024

GSA Capital Partners LLP Lowers Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat

Nov 25, 2024

Nov 24, 2024

Doximity (DOCS) Stock Price, News & Analysis - MarketBeat

Nov 24, 2024

Nov 23, 2024

Banco Santander S.A. Makes New $647,000 Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat

Nov 23, 2024

Nov 20, 2024

JPMorgan raises Doximity target to $48, maintains Neutral rating - Investing.com

Nov 20, 2024

JPMorgan raises Doximity target to $48, maintains Neutral rating By Investing.com - Investing.com UK

Nov 20, 2024

Polen U.S. Small Company Growth Strategy Exited Doximity (DOCS) Due to Multiple Factors - MSN

Nov 19, 2024